Daedalus: A robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors

Nucleic Acids Research

Volumn 39, Issue 21, 2011, Pages

  Bandaranayake, Ashok D ^a,b   Correnti, Colin ^c,d   Ryu, Byoung Y ^b   Brault, Michelle ^b   Strong, Roland K ^a,c,d   Rawlings, David J ^a,b,c,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; IMMUNE RECEPTOR; LENTIVIRUS VECTOR; RECEPTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CHROMATIN; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; GENE SILENCING; GENE VECTOR; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOLECULAR SIZE; MOLECULAR STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN SYNTHESIS;

ACUTE-PHASE PROTEINS; ANIMALS; CELL LINE; CRYSTALLOGRAPHY; CYTOKINES; GENETIC TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; LIPOCALINS; MICE; ONCOGENE PROTEINS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

EID: 82255185569     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr706     Document Type: Article

References (59)

1. Hannig, G. and Makrides, S.C. (1998) Strategies for optimizing heterologous protein expression in Escherichia coli. Trends Biotechnol., 16, 54-60. (Pubitemid 28055472)
2. Baneyx, F. and Mujacic, M. (2004) Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol., 22, 1399-408.
3. Holz, C., Prinz, B., Bolotina, N., Sievert, V., Büssow, K., Simon, B., Stahl, U. and Lang, C. (2003) Establishing the yeast Saccharomyces cerevisiae as a system for expression of human proteins on a proteome-scale. J. Struct. Funct. Genomics, 4, 97-108. (Pubitemid 37356263)
4. Daly, R. and Hearn, M.T.W. (2005) Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J. Mol. Recogn., 18, 119-138, 10.1002/jmr.687. (Pubitemid 40328574)
5. Kost, T.A., Condreay, J.P. and Jarvis, D.L. (2005) Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol., 23, 567-575. (Pubitemid 41724895)
6. Chang, G. (2003) Improvement of glycosylation in insect cells with mammalian glycosyltransferases. J. Biotechnol., 102, 61-71, 10.1016/S0168- 1656(02)00364-4. (Pubitemid 36369204)
7. Chu, L. and Robinson, D.K. (2001) Industrial choices for protein production by large-scale cell culture. Curr. Opin. Biotechnol., 12, 180-187. (Pubitemid 32247406)
8. Bosques, C., Collins, B., Meador, J. III, Sarvaiya, H., Murphy, J., DelloRusso, G., Bulik, D., Hsu, I., Washburn, N., Sipsey, S. et al. (2010) Chinese hamster ovary cells can produce galactose-a-1, 3-galactose antigens on proteins. Nat. Biotechnol., 28, 1153-1156, 10.1038/nbt1110-1153.
9. Oberbek, A., Matasci, M., Hacker, D.L. and Wurm, F.M. (2010) Generation of stable, high-producing CHO cell lines by lentiviral vector-mediated gene transfer in serum-free suspension culture. Biotechnol. Bioeng., 41, 101002/bit.22968.
10. Gaillet, B., Gilbert, R., Broussau, S., Pilotte, A., Malenfant, F., Mullick, A., Garnier, A. and Massie, B. (2010) High-level recombinant protein production in CHO cells using lentiviral vectors and the cumate gene-switch. Biotechnol. Bioeng., 106, 203-215, 10.1002/bit.22698.
11. Hino, S., Fan, J., Taguwa, S., Akasaka, K. and Matsuoka, M. (2004) Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure. Gene Ther., 11, 819-828, 10.1038/sj.gt.3302227. (Pubitemid 38714585)
12. Hofmann, A., Kessler, B., Ewerling, S., Kabermann, A., Brem, G., Wolf, E. and Pfeifer, A. (2006) Epigenetic regulation of lentiviral transgene vectors in a large animal model. Mol. Ther. J. Am. Soc. Gene Ther., 13, 59-66, 10.1016/j.ymthe.2005.07.685. (Pubitemid 41763483)
13. Antoniou, M., Harland, L., Mustoe, T., Williams, S., Holdstock, J., Yague, E., Mulcahy, T., Griffiths, M., Edwards, S., Ioannou, P. et al. (2003) Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing. Genomics, 82, 269-279, 10.1016/S0888-7543(03)00107-1. (Pubitemid 36952300)
14. Williams, S., Mustoe, T., Mulcahy, T., Griffiths, M., Simpson, D., Antoniou, M., Irvine, A., Mountain, A. and Crombie, R. (2005) CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol., 5, 1710.1186/1472-675′-5-17.
15. Zhang, F., Thornhill, S.I., Howe, S.J., Ulaganathan, M., Schambach, A., Sinclair, J., Kinnon, C., Gaspar, H.B., Antoniou, M. and Thrasher, A.J. (2007) Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood, 110, 1448-1457, 10.1182/blood-2006-12- 060814. (Pubitemid 47443959)
16. Zhang, F., Frost, A., Blundell, M. and Bales, O. (2010) A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors. Mol. Ther., 18, 1640-1649, 10.1038/mt.2010.132.
17. Schambach, A., Bohne, J., Baum, C., Hermann, F.G., Egerer, L., von Laer, D. and Giroglou, T. (2006) Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther., 13, 641-645, 10.1038/sj.gt.3302698.
18. Schambach, A., Galla, M., Maetzig, T., Loew, R. and Baum, C. (2007) Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. Mol. Ther. J. Am. Soc. Gene Ther., 15, 1167-1173, 10.1038/sj.mt.6300152. (Pubitemid 46813620)
19. Schmidt, T.G.M. and Skerra, A. (2007) The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins. Nat. Protoc., 2, 1528-1535, 10.1038/nprot.2007.209. (Pubitemid 46952331)
20. Kerns, H.M., Ryu, B.Y., Stirling, B.V., Sather, B.D., Astrakhan, A., Humblet-Baron, S., Liggitt, D. and Rawlings, D.J. (2010) B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia. Blood, 115, 2146-2155, 10.1182/blood-2009-09-241869.
21. Sather, B.D., Ryu, B.Y., Stirling, B.V., Garibov, M., Kerns, H.M., Humblet-Baron, S., Astrakhan, A. and Rawlings, D.J. (2010) Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disorders. Mol. Ther. J. Am. Soc. Gene Ther., 19, 515-525, 10.1038/mt.2010.259.
22. Pflugrath, J.W. (1999) The finer things in X-ray diffraction data collection. Acta Crystallogr. Sect. D Biol. Crystallogr., 55, 1718-1725, 10.1107/S090744499900935X. (Pubitemid 29504426)
23. McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C. and Read, R.J. (2007) Phaser crystallographic software. J. Appl. Crystallogr., 40, 658-674, 10.1107/S0021889807021206. (Pubitemid 47080256)
24. Potterton, E., Briggs, P., Turkenburg, M. and Dodson, E. (2003) A graphical user interface to the CCP4 program suite. Acta Crystallogr. D Biol. Crystallogr., 59, 1131-1137, S0907444903008126 [pii]. (Pubitemid 36872348)
25. Emsley, P. and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr., 60, 2126-2132, S0907444904019158 [pii] 10.1107/S0907444904019158. (Pubitemid 41742764)
26. Murshudov, G.N., Vagin, A.A. and Dodson, E.J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr., 53, 240-255, 10.1107/S0907444996012255 S0907444996012255 [pii]. (Pubitemid 27235885)
27. Painter, J. and Merritt, E.A. (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. Sect. D Biol. Crystallogr., 62, 439-45 10.1107/S0907444906005270.
28. Painter, J. and Merritt, E.A. (2006) TLSMD web server for the generation of multi-group TLS models. J. Appl. Crystallogr., 39, 109-111, 10.1107/S0021889805′38987.
29. Davis, I.W., Leaver-Fay, A., Chen, V.B., Block, J.N., Kapral, G.J., Wang, X., Murray, L.W., Arendall, W.B. III, Snoeyink, J., Richardson, J.S. et al. (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res., 35, W375-W383, gkm216 [pii] 10.1093/nar/gkm216.
30. Seppala, M., Koistinen, H. and Koistinen, R. (2001) Glycodelins. Trends Endocrinol. Metab., 12, 111-117, S1043-2760(00)00365-9 [pii].
31. Yeung, W.S., Lee, K.F., Koistinen, R., Koistinen, H., Seppala, M., Ho, P.C. and Chiu, P.C. (2006) Roles of glycodelin in modulating sperm function. Mol. Cell. Endocrinol., 25, 149-156, S0303-7207(05)00484-3 [pii] 10.1016/j.mce.2005.12.038.
32. Van den Nieuwenhof, I.M., Koistinen, H., Easton, R.L., Koistinen, R., Kamarainen, M., Morris, H.R., Van Die, I., Seppala, M., Dell, A. and Van den Eijnden, D.H. (2000) Recombinant glycodelin carrying the same type of glycan structures as contraceptive glycodelin-A can be produced in human kidney 293 cells but not in Chinese hamster ovary cells. Eur. J. Biochem., 267, 4753-4762, ejb1528 [pii]. (Pubitemid 30619466)
33. Bahram, S., Bresnahan, M., Geraghty, D.E. and Spies, T. (1994) A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl Acad. Sci. USA, 91, 6259-6263. (Pubitemid 24200639)
34. Bauer, S., Willie, S.T., Spies, T. and Strong, R.K. (1998) Expression, purification, crystallization and crystallographic characterization of the human MHC class I related protein MICA. Acta Crystallogr. D Biol. Crystallogr., 54, 451-453. (Pubitemid 28235867)
35. Li, P., Morris, D.L., Willcox, B.E., Steinle, A., Spies, T. and Strong, R.K. (2001) Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol., 2, 443-451, 10.1038/87757 87757 [pii]. (Pubitemid 33706143)
36. Xu, H., Song, L., Kim, M., Holmes, M.A., Kraft, Z., Sellhorn, G., Reinherz, E.L., Stamatatos, L. and Strong, R.K. (2010) Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity. J. Virol., 84, 1076-1088, 10.1128/JVI.02113-09.
37. Pellegrini, M., Mak, T.W. and Ohashi, P.S. (2010) Fighting cancers from within: augmenting tumor immunity with cytokine therapy. Trends Pharmacol. Sci., 31, 356-363, 10.1016/j.tips.2010.05.003.
38. Roy-Ghanta, S. and Orange, J.S. (2010) Use of cytokine therapy in primary immunodeficiency. Clin. Rev. Allergy Immunol., 38, 39-53, 10.1007/s12016-009- 8131-4.
39. Huang, C.-J., Lowe, A.J. and Batt, C.A. (2010) Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market. Appl. Microbiol. Biotechnol., 87, 401-410, 10.1007/s00253-010-2590-7.
40. Mahmood, I. and Green, M.D. (2005) Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins. Clin. Pharmacokinetics, 44, 331-347. (Pubitemid 40663681)
41. Solá, R.J. and Griebenow, K. (2010) Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs: Clin. Immunotherap. Biopharm. Gene Ther., 24, 9.
42. Mackall, C.L., Fry, T.J. and Gress, R.E. (2011) Harnessing the biology of IL-7 for therapeutic application. Nat. Rev. Immunol., 11, 330-342, 10.1038/nri2970.
43. Sasai, K., Aikawa, J.I., Saburi, S., Tojo, H., Tanaka, S., Ogawa, T. and Shiota, K. (1998) Functions of the N-glycans of rat leukemia inhibitory factor expressed in Chinese hamster ovary cells. J. Biochem., 124, 999-1003. (Pubitemid 28544912)
44. Imsoonthornruksa, S., Noisa, P., Parnpai, R. and Ketudat-Cairns, M. (2011) A simple method for production and purification of soluble and biologically active recombinant human leukemia inhibitory factor (hLIF) fusion protein in Escherichia coli. J. Biotechnol., 151, 295-302, 10.1016/j.jbiotec. 2010.12.020.
45. Cotterman, R. and Knoepfler, P.S. (2009) N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b. PLoS ONE, 4, e5799, 10.1371/journal.pone.0005799.
46. Lupu, M. and Storb, R. (2007) Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model. Cancer Res., 5, 14-31.
47. Shin, I.S., Kim, H.R., Nam, M.J. and Youn, H.Y. (2001) Studies of cocktail therapy with multiple cytokines for neoplasia or infectious disease of the dog I. cDNA cloning of canine IL-3 and IL-6. J. Vet. Sci., 2, 115-120.
48. Bendtsen, J.D., Nielsen, H., von Heijne, G. and Brunak, S. (2004) Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol., 340, 783-795, 10.1016/j.jmb.2004.05.028. (Pubitemid 38829638)
49. Corfe, S.A., Gray, A.P. and Paige, C.J. (2007) Generation and characterization of stromal cell independent IL-7 dependent B cell lines. J. Immunol. Methods, 325, 9-19, 10.1016/j.jim.2007.05.010. (Pubitemid 47238287)
50. Cartwright, P., McLean, C., Sheppard, A., Rivett, D., Jones, K. and Dalton, S. (2005) LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development, 132, 885-896, 10.1242/dev.01670. (Pubitemid 40484924)
51. Rawlings, D.J., Sommer, K. and Moreno-Garcia, M.E. (2006) The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes. Nat. Rev. Immunol., 6, 799-812, 10.1038/nri1944. (Pubitemid 44631649)
52. Sommer, K., Guo, B., Pomerantz, J.L., Bandaranayake, A.D., Ovechkina, Y.L., Moreno-garci, M.E. and Rawlings, D.J. (2005) Phosphorylation of the CARMA1 linker controls NF-kB activation. Immunity, 23, 561-574, 10.1016/j.immuni.2005. 09.014. (Pubitemid 41779479)
53. Srimathi, T., Robbins, S.L., Dubas, R.L., Hasegawa, M., Inohara, N. and Park, Y.C. (2008) Monomer/dimer transition of the caspase-recruitment domain of human Nod1. Biochemistry, 47, 1319-1325, 10.1021/bi7016602. (Pubitemid 351198708)
54. Goetz, D.H., Holmes, M.A., Borregaard, N., Bluhm, M.E., Raymond, K.N. and Strong, R.K. (2002) The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol. Cell, 10, 1033-1043. (Pubitemid 36001971)
55. Strong, R.K., Bratt, T., Cowland, J.B., Borregaard, N., Wiberg, F.C. and Ewald, A.J. (1998) Expression, purification, crystallization and crystallographic characterization of dimeric and monomeric human neutrophil gelatinase associated lipocalin (NGAL). Acta Crystallogr. Sect. D, Biol. Crystallogr., 54, 93-95. (Pubitemid 28111123)
56. Goetz, D.H., Willie, S.T., Armen, R.S., Bratt, T., Borregaard, N. and Strong, R.K. (2000) Ligand preference inferred from the structure of neutrophil gelatinase associated lipocalin. Society, 39, 1935-1941. (Pubitemid 30124000)
57. Otero, J.H., Lizák, B. and Hendershot, L.M. (2010) Life and death of a BiP substrate. Semin. Cell Dev. Biol., 21, 472-478, 10.1016/j.semcdb.2009. 12.008.
58. Williams, S., Mustoe, T., Mulcahy, T., Griffiths, M., Simpson, D., Antoniou, M., Irvine, A., Mountain, A. and Crombie, R. (2005) CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol., 5, 17, 10.1186/1472-675′-5-17.
59. Benton, T., Chen, T., McEntee, M., Fox, B., King, D., Crombie, R., Thomas, T.C. and Bebbington, C. (2002) The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein. Cytotechnology, 38, 43-46. (Pubitemid 35307407)